Akorn: From financial troubles to a shutdown and intensifying drug shortages

It has been about a month since a U.S. drugmaker closed all operations, and since then, at least 13 drugs have gone into shortage and four are discontinued. 

Read the full post on Becker's Hospital Review - Healthcare News